These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19490048)

  • 1. Seizure frequency in pregnant women treated with lamotrigine monotherapy.
    Sabers A; Petrenaite V
    Epilepsia; 2009 Sep; 50(9):2163-6. PubMed ID: 19490048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study.
    de Haan GJ; Edelbroek P; Segers J; Engelsman M; Lindhout D; Dévilé-Notschaele M; Augustijn P
    Neurology; 2004 Aug; 63(3):571-3. PubMed ID: 15304599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
    Neurology; 2015 Sep; 85(10):866-72. PubMed ID: 26085607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is lamotrigine a significant human teratogen? Observations from the Australian Pregnancy Register.
    Vajda FJ; Graham JE; Hitchcock AA; O'Brien TJ; Lander CM; Eadie MJ
    Seizure; 2010 Nov; 19(9):558-61. PubMed ID: 20739196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy.
    Ohman I; Beck O; Vitols S; Tomson T
    Epilepsia; 2008 Jun; 49(6):1075-80. PubMed ID: 18076642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2005 AES annual course: evidence used to treat women with epilepsy.
    Pennell PB
    Epilepsia; 2006; 47 Suppl 1():46-53. PubMed ID: 17044826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Algorithm for lamotrigine dose adjustment before, during, and after pregnancy.
    Sabers A
    Acta Neurol Scand; 2012 Jul; 126(1):e1-4. PubMed ID: 22150770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.
    Tomson T; Perucca E; Battino D
    Epilepsia; 2004 Oct; 45(10):1171-5. PubMed ID: 15461670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study).
    Tompson DJ; Ali I; Oliver-Willwong R; Job S; Zhu L; Lemme F; Hammer AE; Vuong A; Messenheimer JA
    Epilepsia; 2008 Mar; 49(3):410-7. PubMed ID: 17825077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry.
    EURAP Study Group
    Neurology; 2006 Feb; 66(3):354-60. PubMed ID: 16382034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of pregnancy and childbirth on the metabolism of lamotrigine.
    Pennell PB; Newport DJ; Stowe ZN; Helmers SL; Montgomery JQ; Henry TR
    Neurology; 2004 Jan; 62(2):292-5. PubMed ID: 14745072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate effects on kinetics of lamotrigine in pregnancy and treatment with oral contraceptives.
    Tomson T; Luef G; Sabers A; Pittschieler S; Ohman I
    Neurology; 2006 Oct; 67(7):1297-9. PubMed ID: 17030773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of monitoring strategies on seizures in pregnant women on lamotrigine: a meta-analysis.
    Pirie DA; Al Wattar BH; Pirie AM; Houston V; Siddiqua A; Doug M; Bagary M; Greenhill L; Khan KS; McCorry D; Thangaratinam S
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():26-31. PubMed ID: 24211103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual changes in lamotrigine plasma concentrations during pregnancy.
    Petrenaite V; Sabers A; Hansen-Schwartz J
    Epilepsy Res; 2005 Jul; 65(3):185-8. PubMed ID: 16084694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diurnal lamotrigine plasma level fluctuations: clinical significance and indication of shorter half-life with chronic administration.
    Nielsen KA; Dahl M; Tømmerup E; Hansen Bá; Erdal J; Wolf P
    Epilepsy Behav; 2008 Oct; 13(3):470-3. PubMed ID: 18611447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.
    Pennell PB; Peng L; Newport DJ; Ritchie JC; Koganti A; Holley DK; Newman M; Stowe ZN
    Neurology; 2008 May; 70(22 Pt 2):2130-6. PubMed ID: 18046009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of comedication on lamotrigine clearance in Korean epilepsy patients.
    Kim HJ; Kim TE; Joo EY; Seo DW; Lee SY; Hong SB
    Clin Chim Acta; 2015 Jan; 438():269-73. PubMed ID: 25218785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxcarbazepine in pregnancy: clinical experience in Argentina.
    Meischenguiser R; D'Giano CH; Ferraro SM
    Epilepsy Behav; 2004 Apr; 5(2):163-7. PubMed ID: 15123016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.
    Holmes LB; Mittendorf R; Shen A; Smith CR; Hernandez-Diaz S
    Arch Neurol; 2011 Oct; 68(10):1275-81. PubMed ID: 21670385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy.
    Wegner I; Edelbroek P; de Haan GJ; Lindhout D; Sander JW
    Epilepsia; 2010 Dec; 51(12):2500-2. PubMed ID: 21204816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.